Ajooni Ebitda from 2010 to 2024

AJOONI Stock   7.83  0.04  0.51%   
Ajooni Biotech's EBITDA is increasing over the years with slightly volatile fluctuation. Overall, EBITDA is expected to go to about 46.5 M this year. From 2010 to 2024 Ajooni Biotech EBITDA quarterly data regression line had arithmetic mean of  13,986,409 and slope of  3,330,021. View All Fundamentals
 
EBITDA  
First Reported
2018-06-30
Previous Quarter
18.5 M
Current Value
10 M
Quarterly Volatility
4.2 M
 
Covid
Check Ajooni Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ajooni Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.6 M, Selling General Administrative of 8.3 M or Other Operating Expenses of 405 M, as well as many indicators such as . Ajooni financial statements analysis is a perfect complement when working with Ajooni Biotech Valuation or Volatility modules.
  
This module can also supplement various Ajooni Biotech Technical models . Check out the analysis of Ajooni Biotech Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ajooni Stock

Ajooni Biotech financial ratios help investors to determine whether Ajooni Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajooni with respect to the benefits of owning Ajooni Biotech security.